Patent details
LUC00195 Product Name: Sacubitril et valsartan, sous forme de complexe de sel de sodium sacubitril valsartan, c’est-à-dire [((S)-N-valéryl-N-{[2'-(1H-tétrazole-5-yl)-biphényl-4-yl]-méthyl}-valine) ((2R,4S)-5-biphényl-4-yl-4-(3-carboxy-propionylamino)-2-méthyl-ester éthylique d'acide pentanoïque)]Na3 ● x H2O, dans lequel x est 0 à 3
Basic Information
- Publication number:
- LUC00195
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP101760940
- Legal Status:
- Lapsed
- Application number:
- LUC00195
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/15/1058
- Marketing Authorization Type:
- Marketing Authorization Date:
- 23/11/2015
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 11/01/2021
- First Marketing Authorization date:
- 23/11/2015
- Grant date:
- 04/10/2024
- Activation date:
- Publication date:
- 11/01/2021
- Lapsed date:
- Expiration date:
- Renunciation date:
- 15/05/2025
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 23/11/2030
- SPC Extension Expiration:
- 23/11/2030
- Rejection date:
- Withdrawal date:
Owner
- From:
- 11/01/2021
- Name:
- Novartis Pharma AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 11/01/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2021/03
- Publication date:
- 02/02/2021
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- MED
- Bulletin edition number:
- 2025/07
- Publication date:
- 04/06/2025
- Description:
- Section K : Modifications and recordals into the register
3
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2024/13
- Publication date:
- 05/11/2024
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Deed
Surrender
- Change Kind/ Decision Type:
- Total - Renunciation
- Deed Number:
- RC20250000163A
- Date Registered:
- 15/05/2025
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Removed Pledgee
- Name:
- Address:
Other
1
- Note:
- (11/01/2021) Suspension de la procédure de délivrance sur requête du déposant / Suspension of the grant procedure at the request of the applicant
2
- Note:
- suspension levée à partir du 28 juin 2023
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 08/06/2023 | Incoming Correspondence (Post) | 1 |
| 11/01/2021 | Application Form | 3 |
| 11/01/2021 | MA publication | 16 |
| 11/01/2021 | General Document | 7 |
| 11/01/2021 | Outgoing Correspondence | 1 |
| 11/01/2021 | Marketing authorization | 3 |
| 11/01/2021 | Summary of the product caracteristics | 49 |
| 11/01/2021 | General Document | 2 |
| 11/01/2021 | Marketing authorization | 115 |
| 07/03/2024 | Outgoing Correspondence | 1 |
| 11/01/2021 | Publication | 1 |
| 04/10/2024 | Publication | 1 |
| 04/10/2024 | Certificate | 1 |
| 04/10/2024 | Outgoing Correspondence | 1 |
| 15/05/2025 | General Document | 1 |
| 15/05/2025 | Outgoing Correspondence | 2 |
| 15/05/2025 | General Document | 1 |
| 15/05/2025 | Incoming Correspondence (Email) | 2 |
| 15/05/2025 | Request For Change | 1 |
| 19/05/2025 | Outgoing Correspondence | 1 |